Subtle blood‐brain barrier leakage rate and spatial extent: Considerations for dynamic contrast‐enhanced MRI
Open accessAbstract
Purpose: Dynamic contrast‐enhanced (DCE) MRI can be used to measure blood‐brain barrier (BBB) leakage. In neurodegenerative disorders such as small vessel disease and dementia, the leakage can be very subtle and the corresponding signal can be rather noisy. For these reasons, an optimized DCE‐MRI measurement and study design is required. To this end, a new measure indicative of the spatial extent of leakage is introduced and the effects of scan time and sample size are explored. Methods: Dual‐time resolution DCE‐MRI was performed in 16 patients with early Alzheimer's disease (AD) and 17 healthy controls. The leakage rate (K i) and volume fraction of detectable leaking tissue (v L) to quantify the spatial extent of BBB leakage were calculated in cortical gray matter and white matter using noise‐corrected histogram analysis of leakage maps. Computer simulations utilizing realistic K i histograms, mimicking the strong effect of noise and variation in K i values, were performed to understand the influence of scan time on the estimated leakage. Results: The mean K i was very low (order of 10−4 min−1) and highly influenced by noise, causing the K i to be increasingly overestimated at shorter scan times. In the white matter, the K i was not different between patients with early AD and controls, but was higher in the cortex for patients, reaching significance after 14.5 min of scan time. To detect group differences, v L proved more suitable, showing significantly higher values for patients compared with controls in the cortex after 8 minutes of scan time, and in white matter after 15.5 min. Conclusions: Several ways to improve the sensitivity of a DCE‐MRI experiment to subtle BBB leakage were presented. We have provided v L as an attractive and potentially more time‐efficient alternative to detect group differences in subtle and widespread blood‐brain barrier leakage compared with leakage rate K i. Recommendations on group size and scan time are made based on statistical power calculations to aid future research.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Recent neuroimaging studies in individuals with MCI and early AD reveal BBB breakdown in the hippocampus, including its CA1 and dentate gyrus subfields, and several gray and white matter regions, before brain atrophy and dementia.
“Recent neuroimaging studies in individuals with mild cognitive impairment (MCI) and early AD reveal BBB breakdown in the hippocampus, including its CA1 and dentate gyrus subfields (421), and several gray and white matter regions (220-222), respectively, before brain atrophy and dementia.”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [221]
The Results report a greater fraction of detectable leaking tissue in cortical gray matter and normal-appearing white matter in patients with early AD than in controls. The paper does not establish that this leakage preceded brain atrophy or dementia; its study included patients already diagnosed with mild dementia or MCI due to AD (Imaging: subjects). The hippocampal subfields are attached to a different citation in the citing sentence. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · see citing works
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102 · see citing works
Cluster-extent based thresholding in fMRI analyses: Pitfalls and recommendations
Woo, C.-W., Krishnan, A., & Wager, T. D. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.12.058 · Cited by 1,253 · see citing works
Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease
Erickson, M. A., & Banks, W. A. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.135 · Cited by 572 · see citing works
Flagged first, then by citations
Research works printed but not linked: 31
- Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12:483-497.
- Sourbron S, Ingrisch M, Siefert A, Reiser M, Herrmann K. Quantifica- tion of cerebral blood flow, cerebral blood volume, and blood-brain-bar- rier leakage with DCE-MRI. Magn Reson Med. 2009;62:205-217.
- Larsson HBW, Courivaud F, Rostrup E, Hansen AE. Measurement of brain perfusion, blood volume, and blood-brain barrier permeability, using dynamic contrast-enhanced T1-weighted MRI at 3 tesla. Magn Reson Med. 2009;62:1270-1281.
- Cramer SP, Larsson HBW. Accurate determination of blood-brain bar- rier permeability using dynamic contrast-enhanced T1-weighted MRI: a simulation and in vivo study on healthy subjects and multiple sclerosis patients. J Cereb Blood Flow Metab. 2014;34:1655-1665.
- Khalifa F, Soliman A, El-Baz A, et al. Models and methods for analyz- ing DCE-MRI: a review. Med Phys. 2014;41:124301.
- Starr JM, Farrall AJ, Armitage P, McGurn B, Wardlaw JM. Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study. Psychiatry Res -Neuroimaging. 2009;171:232-241.
- Armitage PA, Farrall AJ, Carpenter TK, Doubal FN, Wardlaw JM. Use of dynamic contrast-enhanced MRI to measure subtle blood-brain bar- rier abnormalities. Magn Reson Imaging. 2011;29:305-314.
- Barnes SR, Ng TSC, Montagne A, Law M, Zlokovic BV, Jacobs RE. Optimal acquisition and modeling parameters for accurate assessment of low K trans blood-brain barrier permeability using dynamic contrast- enhanced MRI. Magn Reson Med. 2016;75:1967-1977.
- Taheri S, Gasparovic C, Huisa BN, et al. Blood-brain barrier permeabil- ity abnormalities in vascular cognitive impairment. Stroke. 2011;42:2158-2163.
- Taheri S, Gasparovic C, Shah NJ, Rosenberg GA. Quantitative measure- ment of blood-brain barrier permeability in human using dynamic con- trast-enhanced MRI with fast T1 mapping. Magn Reson Med. 2011;65:1036-1042.
- Bronge L, Wahlund L-OO. Contrast-enhanced MRI of White Matter Lesions in Patients with Blood-Brain Barrier Dysfunction. Dement Geri- atr Cogn Disord. 2000;11:477-481.
- van de Haar HJ, Burgmans S, Jansen JFA, et al. Blood-brain barrier leakage in early Alzheimer's disease. Radiology. 2016;281:527-535.
- Jelescu IO, Leppert IR, Narayanan S, Ara ujo D, Arnold DL, Pike GB. Dual-temporal resolution dynamic contrast-enhanced MRI protocol for blood-brain barrier permeability measurement in enhancing multiple sclerosis lesions. J Magn Reson Imaging. 2011;33:1291-1300.
- Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341-355.
- de Boer R, Vrooman HA, van der Lijn F, et al. White matter lesion extension to automatic brain tissue segmentation on MRI. NeuroImage. 2009;45:1151-1161.
- Haroon HA, Buckley DL, Patankar TA, et al. A Comparison of Ktrans Measurements Obtained with Conventional and First Pass Pharmacoki- netic Models in Human Gliomas. J Magn Reson Imaging. 2004;19:527- 536.
- Li KL, Zhu XP, Waterton J, Jackson A. Improved 3D quantitative map- ping of blood volume and endothelial permeability in brain tumors. J Magn Reson Imaging. 2000;12:347-357.
- Lavini C, Verhoeff JJC. Reproducibility of the gadolinium concentration measurements and of the fitting parameters of the vascular input func- tion in the superior sagittal sinus in a patient population. Magn Reson Imaging. 2010;28:1420-1430.
- Pintaske J, Martirosian P, Graf H, et al. Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla. Invest Radiol. 2006;41:213-221.
- Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3:1-7.
- Aerts HJWL, Jaspers K, Backes WH. The precision of pharmacokinetic parameters in dynamic contrast-enhanced magnetic resonance imaging: the effect of sampling frequency and duration. Phys Med Biol. 2011;56:5665-5678.
- Zar JH. Biostatistical Analysis, 4th edn. Prentice Hall; 1999.
- McGrath DM, Bradley DP, Tessier JL, Lacey T, Taylor CJ, Parker GJM. Comparison of model-based arterial input functions for dynamic con- trast-enhanced MRI in tumor bearing rats. Magn Reson Med. 2009;61:1173-1184.
- Wardlaw JM, Sandercock PAG, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke. 2003;34:806-811.
- Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2003;17:509-520.
- Lee MH, Smyser CD, Shimony JS. Resting-state fMRI: a review of methods and clinical applications. Am J Neuroradiol. 2013;34:1866- 1872.
- Heye AK, Culling RD, Vald es Hern andez MDC, Thrippleton MJ, Ward- law JM. Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review. Neuroimage Clin. 2014;6:262-274.
- Heye AK, Thrippleton MJ, Armitage PA, et al. Tracer kinetic modelling for DCE-MRI quantification of subtle blood-brain barrier permeability. NeuroImage. 2016;125:446-455.
- Cao Y, Li D, Shen Z, Normolle D. Sensitivity of Quantitative Metrics Derived from DCE MRI and a Pharmacokinetic Model to Image Quality and Acquisition Parameters. Acad Radiol. 2010;17:468-478.
- Kershaw LE, Cheng HLM. Temporal resolution and SNR requirements for accurate DCE-MRI data analysis using the AATH model. Magn Reson Med. 2010;64:1772-1780.
- Seelig A, Gottschlich R, Devant RM. A method to determine the ability of drugs to diffuse through the blood-brain barrier. Proc Natl Acad Sci USA. 1994;91:68-72.
Cited by
Sorted by citations
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076 · see citing works
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,294 · see citing works
The role of brain vasculature in neurodegenerative disorders
Sweeney, M. D., Kisler, K., Montagne, A., Toga, A. W., & Zlokovic, B. V. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0234-x · Cited by 998 · see citing works
Vascular dysfunction—The disregarded partner of Alzheimer's disease
Sweeney, M. D., Montagne, A., Sagare, A. P., Nation, D. A., Schneider, L. S., Chui, H. C., Harrington, M. G., Pa, J., Law, M., Wang, D. J. J., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.07.222 · Cited by 711 · see citing works
Self-citationAlzheimer’s disease: A matter of blood–brain barrier dysfunction?
Montagne, A., Zhao, Z., & Zlokovic, B. V. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171406 · Cited by 672 · see citing works
Thrippleton, M. J., Backes, W. H., Sourbron, S., Ingrisch, M., van Osch, M. J. P., Dichgans, M., Fazekas, F., Ropele, S., Frayne, R., van Oostenbrugge, R. J., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.013 · Cited by 252 · see citing works
Self-citationBlood-brain barrier leakage in Alzheimer’s disease: From discovery to clinical relevance
Nehra, G., Bauer, B., & Hartz, A. M. S. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108119 · Cited by 127 · see citing works
Basal lamina changes in neurodegenerative disorders
Nguyen, B., Bix, G., & Yao, Y. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00502-y · Cited by 75 · see citing works
When the infectious environment meets the AD brain
Ganz, T., Fainstein, N., & Ben-Hur, T. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00559-3 · Cited by 39 · see citing works
Yin, H., Lu, Z., Deng, Y., Tian, X., & Gong, Q. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102952 · Cited by 6 · see citing works
- Authors
- van de Haar, H. J., Jansen, J. F. A., Jeukens, C. R. L. P. N., Burgmans, S., van Buchem, M. A., Muller, M., Hofman, P. A. M., Verhey, F. R. J., van Osch, M. J. P., & Backes, W. H.
- Affiliations
- Department of Radiology and Nuclear Medicine Maastricht University Medical Center PO box 5800 Maastricht 6202 AZ The Netherlands
- Maastricht University Medical Centre (NL)
- Department of Radiology Leiden University Medical Center PO box 9600 Leiden 2300 RC The Netherlands
- Leiden University Medical Center (NL)
- Corresponding author
- Backes, Walter H.
- ORCID
- Venue
- Medical Physics
- Publisher
- Wiley
- Published
- 2017-07-10
- Volume
- 44
- Issue
- 8
- Pages
- 4112-4125
- ISSN
- 0094-2405 (ISSN-L)
- 2473-4209
- OpenAlex
- W2613536437
- Cited by
- 85
- References
- 4
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 7 · 2023: 7 · 2022: 17 · 2021: 12 · 2020: 11 · 2019: 12 · 2018: 7 · 2017: 2
- FWCI
- 6.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Medical Physics (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Internationale Stichting Alzheimer Onderzoek (10553)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced Neuroimaging Techniques and Applications
- Keywords
- blood-brain barrier disruption, dynamic contrast-enhanced MRI, leakage rate, early Alzheimer's disease, cerebral small vessel disease, scan time, sample size, noise correction, histogram analysis, statistical power, cortical gray matter, white matter
- MeSH terms
- Blood-Brain Barrier, Contrast Media, Humans, Magnetic Resonance Imaging, White Matter, Gray Matter
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review